Gasparian AV - Search Results

1

Anti-malaria drug blocks proteotoxic stress response: anti-cancer implications.

Neznanov N, Gorbachev AV, Neznanova L, Komarov AP, Gurova KV, Gasparian AV, Banerjee AK, Almasan A, Fairchild RL, Gudkov AV. Neznanov N, et al. Among authors: gasparian av. Cell Cycle. 2009 Dec;8(23):3960-70. doi: 10.4161/cc.8.23.10179. Epub 2009 Dec 25. Cell Cycle. 2009. PMID: 19901558 Free PMC article.

2

Inhibition of encephalomyocarditis virus and poliovirus replication by quinacrine: implications for the design and discovery of novel antiviral drugs.

Gasparian AV, Neznanov N, Jha S, Galkin O, Moran JJ, Gudkov AV, Gurova KV, Komar AA. Gasparian AV, et al. J Virol. 2010 Sep;84(18):9390-7. doi: 10.1128/JVI.02569-09. Epub 2010 Jul 14. J Virol. 2010. PMID: 20631142 Free PMC article.

3

Curaxins: anticancer compounds that simultaneously suppress NF-κB and activate p53 by targeting FACT.

Gasparian AV, Burkhart CA, Purmal AA, Brodsky L, Pal M, Saranadasa M, Bosykh DA, Commane M, Guryanova OA, Pal S, Safina A, Sviridov S, Koman IE, Veith J, Komar AA, Gudkov AV, Gurova KV. Gasparian AV, et al. Sci Transl Med. 2011 Aug 10;3(95):95ra74. doi: 10.1126/scitranslmed.3002530. Sci Transl Med. 2011. PMID: 21832239 Free PMC article.

4

Quinacrine inhibits the epidermal dendritic cell migration initiating T cell-mediated skin inflammation.

Gorbachev AV, Gasparian AV, Gurova KV, Gudkov AV, Fairchild RL. Gorbachev AV, et al. Among authors: gasparian av. Eur J Immunol. 2007 Aug;37(8):2257-67. doi: 10.1002/eji.200636708. Eur J Immunol. 2007. PMID: 17634953 Free article.

5

Core circadian protein CLOCK is a positive regulator of NF-κB-mediated transcription.

Spengler ML, Kuropatwinski KK, Comas M, Gasparian AV, Fedtsova N, Gleiberman AS, Gitlin II, Artemicheva NM, Deluca KA, Gudkov AV, Antoch MP. Spengler ML, et al. Among authors: gasparian av. Proc Natl Acad Sci U S A. 2012 Sep 11;109(37):E2457-65. doi: 10.1073/pnas.1206274109. Epub 2012 Aug 15. Proc Natl Acad Sci U S A. 2012. PMID: 22895791 Free PMC article.

6

9-Aminoacridine-based anticancer drugs target the PI3K/AKT/mTOR, NF-kappaB and p53 pathways.

Guo C, Gasparian AV, Zhuang Z, Bosykh DA, Komar AA, Gudkov AV, Gurova KV. Guo C, et al. Among authors: gasparian av. Oncogene. 2009 Feb 26;28(8):1151-61. doi: 10.1038/onc.2008.460. Epub 2009 Jan 12. Oncogene. 2009. PMID: 19137016

7

Targeting transcription factor NFkappaB: comparative analysis of proteasome and IKK inhibitors.

Gasparian AV, Guryanova OA, Chebotaev DV, Shishkin AA, Yemelyanov AY, Budunova IV. Gasparian AV, et al. Cell Cycle. 2009 May 15;8(10):1559-66. doi: 10.4161/cc.8.10.8415. Epub 2009 May 13. Cell Cycle. 2009. PMID: 19372735

8

The role of IKK in constitutive activation of NF-kappaB transcription factor in prostate carcinoma cells.

Gasparian AV, Yao YJ, Kowalczyk D, Lyakh LA, Karseladze A, Slaga TJ, Budunova IV. Gasparian AV, et al. J Cell Sci. 2002 Jan 1;115(Pt 1):141-51. doi: 10.1242/jcs.115.1.141. J Cell Sci. 2002. PMID: 11801732

9

Selenium compounds inhibit I kappa B kinase (IKK) and nuclear factor-kappa B (NF-kappa B) in prostate cancer cells.

Gasparian AV, Yao YJ, Lü J, Yemelyanov AY, Lyakh LA, Slaga TJ, Budunova IV. Gasparian AV, et al. Mol Cancer Ther. 2002 Oct;1(12):1079-87. Mol Cancer Ther. 2002. PMID: 12481431

10

Effects of IKK inhibitor PS1145 on NF-kappaB function, proliferation, apoptosis and invasion activity in prostate carcinoma cells.

Yemelyanov A, Gasparian A, Lindholm P, Dang L, Pierce JW, Kisseljov F, Karseladze A, Budunova I. Yemelyanov A, et al. Oncogene. 2006 Jan 19;25(3):387-98. doi: 10.1038/sj.onc.1209066. Oncogene. 2006. PMID: 16170348

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

54 results

Search Page